WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

C CARDIOVASCULAR SYSTEM

This group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, and C03.


C07 BETA BLOCKING AGENTS
C07F BETA BLOCKING AGENTS, OTHER COMBINATIONS

Beta blocking agents in combination with ACE inhibitors are classified in C09BX - ACE inhibitors, other combinations.
Beta blocking agents in combination with ARBs are classified in C09DX - Angiotensin II receptor blockers (ARBs), other combinations.

See comments to C02L concerning the principles for assignment of DDDs for combined preparations.


C07FB Beta blocking agents and calcium channel blockers
C07FX Beta blocking agents, other combinations

Combinations of propranolol and hydralazine or dihydralazine are classified in C07FX01.

Last updated: 2024-01-26